Table 2 Clinical characteristics of patients pre- and post-BTXA injection
Characteristics n = 22 |  | Mean ± 1 Standard deviation (Range) | P Value | |||
|---|---|---|---|---|---|---|
Pre-BTXA injection | Post-BTXA injection | |||||
Reciprocal stereoacuity |  | 0.012 ± 0.012 | (0.000–0.040) | 0.012 ± 0.007 | (0.003–0.033) | 0.887 |
Deviation (PD) | Distance | 25.09 ± 10.99 | (6.0–45.0) | 11.32 ± 7.23PD | (0.0–25.0) | <  0.001 |
Near | 27.73 ± 11.60 | (6.0–45.0) | 11.89 ± 8.40 | (0.0–30.0) | < 0.001 | |
Convergence (PD) | Distance | 15.20 ± 9.25 | (0.5–40.0) | 24.64 ± 10.97 | (8.0–45.0) | < 0.001 |
Near | 21.32 ± 9.95 | (8.0–40.0) | 30.27 ± 10.91 | (10.0–50.0) | 0.003 | |
Divergence (PD) | Distance | 7.24 ± 3.94 | (2.0–16.0) | 11.50 ± 5.00 | (5.0–20.0) | < 0.001 |
Near | 8.14 ± 4.97 | (1.0–20.0) | 12.59 ± 7.42 | (3.0–35.0) | 0.021 | |
Vergence (PD) | Distance | 22.48 ± 11.29 | (3.5–54.0) | 36.14 ± 12.64 | (16.0–57.0) | < 0.001 |
Near | 29.45 ± 13.49 | (14.0–55.0) | 42.86 ± 15.10 | (18.0–75.0) | 0.003 | |
Accommodation (D) | OD | 7.61 ± 3.69 | (1.00–13.25) | 10.32 ± 3.51 | (5.00–19.00) | 0.011 |
OS | 7.38 ± 3.68 | (1.00–13.75) | 10.59 ± 3.89 | (5.25–19.50) | 0.004 | |
Gradient AC/A (PD/D) |  | 7.45 ± 2.99 | (2.0–14.0) | 5.27 ± 2.31 | (2.0–10.0) | 0.001 |